Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Grénman S[au]:

Revised FIGO staging for carcinoma of the cervix uteri. Bhatla N et al. Int J Gynaecol Obstet. (2019)

Psychosexual health in gynecologic cancer. Boa R et al. Int J Gynaecol Obstet. (2018)

A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients. Tumiati M et al. Clin Cancer Res. (2018)

Search results

Items: 1 to 50 of 193

1.

A longitudinal analysis of CA125 glycoforms in the monitoring and follow up of high grade serous ovarian cancer.

Salminen L, Nadeem N, Jain S, Grènman S, Carpén O, Hietanen S, Oksa S, Lamminmäki U, Pettersson K, Gidwani K, Huhtinen K, Hynninen J.

Gynecol Oncol. 2019 Dec 27. pii: S0090-8258(19)31846-3. doi: 10.1016/j.ygyno.2019.12.025. [Epub ahead of print]

2.

ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors.

Kaipio K, Chen P, Roering P, Huhtinen K, Mikkonen P, Östling P, Lehtinen L, Mansuri N, Korpela T, Potdar S, Hynninen J, Auranen A, Grénman S, Wennerberg K, Hautaniemi S, Carpén O.

J Pathol. 2020 Feb;250(2):159-169. doi: 10.1002/path.5356. Epub 2019 Dec 3.

PMID:
31595974
3.

Open Source Infrastructure for Health Care Data Integration and Machine Learning Analyses.

Isoviita VM, Salminen L, Azar J, Lehtonen R, Roering P, Carpén O, Hietanen S, Grénman S, Hynninen J, Färkkilä A, Hautaniemi S.

JCO Clin Cancer Inform. 2019 Aug;3:1-16. doi: 10.1200/CCI.18.00132.

4.

Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study.

Laasik M, Kemppainen J, Auranen A, Hietanen S, Grénman S, Seppänen M, Hynninen J.

Cancer Imaging. 2019 May 29;19(1):27. doi: 10.1186/s40644-019-0215-7.

5.

Decorin Expression in Human Vulva Carcinoma: Oncosuppressive Effect of Decorin cDNA Transduction on Carcinoma Cells.

Nyman MC, Jokilammi AB, Boström PC, Kurki SH, Sainio AO, Grenman SE, Orte KJ, Hietanen SH, Elenius K, Järveläinen HT.

J Histochem Cytochem. 2019 Jul;67(7):511-522. doi: 10.1369/0022155419845373. Epub 2019 Apr 22.

PMID:
31009269
6.

Revised FIGO staging for carcinoma of the cervix uteri.

Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, Kehoe ST, Konishi I, Olawaiye AB, Prat J, Sankaranarayanan R, Brierley J, Mutch D, Querleu D, Cibula D, Quinn M, Botha H, Sigurd L, Rice L, Ryu HS, Ngan H, Mäenpää J, Andrijono A, Purwoto G, Maheshwari A, Bafna UD, Plante M, Natarajan J.

Int J Gynaecol Obstet. 2019 Apr;145(1):129-135. doi: 10.1002/ijgo.12749. Epub 2019 Jan 17. Review. Erratum in: Int J Gynaecol Obstet. 2019 Nov;147(2):279-280.

PMID:
30656645
7.

Psychosexual health in gynecologic cancer.

Boa R, Grénman S.

Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:147-152. doi: 10.1002/ijgo.12623.

PMID:
30306581
8.

Identifying differentially methylated sites in samples with varying tumor purity.

Häkkinen A, Alkodsi A, Facciotto C, Zhang K, Kaipio K, Leppä S, Carpén O, Grénman S, Hynninen J, Hietanen S, Lehtonen R, Hautaniemi S.

Bioinformatics. 2018 Sep 15;34(18):3078-3085. doi: 10.1093/bioinformatics/bty310.

PMID:
29912358
9.

A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients.

Tumiati M, Hietanen S, Hynninen J, Pietilä E, Färkkilä A, Kaipio K, Roering P, Huhtinen K, Alkodsi A, Li Y, Lehtonen R, Erkan EP, Tuominen MM, Lehti K, Hautaniemi SK, Vähärautio A, Grénman S, Carpén O, Kauppi L.

Clin Cancer Res. 2018 Sep 15;24(18):4482-4493. doi: 10.1158/1078-0432.CCR-17-3770. Epub 2018 Jun 1.

10.

Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer.

Kozłowska E, Färkkilä A, Vallius T, Carpén O, Kemppainen J, Grénman S, Lehtonen R, Hynninen J, Hietanen S, Hautaniemi S.

Cancer Res. 2018 Jul 15;78(14):4036-4044. doi: 10.1158/0008-5472.CAN-17-3746. Epub 2018 May 16.

11.

Clinical Value of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Response Evaluation after Primary Treatment of Advanced Epithelial Ovarian Cancer.

Hynninen J, Laasik M, Vallius T, Kemppainen J, Grönroos S, Virtanen J, Casado J, Hautaniemi S, Grenman S, Seppänen M, Auranen A.

Clin Oncol (R Coll Radiol). 2018 Aug;30(8):507-514. doi: 10.1016/j.clon.2018.04.007. Epub 2018 May 9.

PMID:
29753662
12.

HLA-G and vertical mother-to-child transmission of human papillomavirus infection.

Louvanto K, Roger M, Faucher MC, Syrjänen K, Grenman S, Syrjänen S.

Hum Immunol. 2018 Jun;79(6):471-476. doi: 10.1016/j.humimm.2018.03.002. Epub 2018 Mar 12.

PMID:
29544814
13.

Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma.

Huvila J, Laajala TD, Edqvist PH, Mardinoglu A, Talve L, Pontén F, Grénman S, Carpén O, Aittokallio T, Auranen A.

Gynecol Oncol. 2018 Apr;149(1):173-180. doi: 10.1016/j.ygyno.2018.02.016. Epub 2018 Mar 2.

PMID:
29486992
14.

18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer.

Vallius T, Hynninen J, Kemppainen J, Alves V, Auranen K, Matomäki J, Oksa S, Virtanen J, Grénman S, Auranen A, Seppänen M.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1224-1232. doi: 10.1007/s00259-018-3961-z. Epub 2018 Feb 23.

PMID:
29476227
15.

Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Endometrial Cancer Cells In Vitro.

Kuittinen T, Rovio P, Staff S, Luukkaala T, Kallioniemi A, Grénman S, Laurila M, Mäenpää J.

Anticancer Res. 2017 Dec;37(12):6575-6581.

PMID:
29187432
16.

Long-term Follow-up After Endometrial Ablation in Finland: Cancer Risks and Later Hysterectomies.

Soini T, Rantanen M, Paavonen J, Grénman S, Mäenpää J, Pukkala E, Gissler M, Hurskainen R.

Obstet Gynecol. 2017 Sep;130(3):554-560. doi: 10.1097/AOG.0000000000002166.

PMID:
28796675
17.

Association of asymptomatic bacterial vaginosis with persistence of female genital human papillomavirus infection.

Kero K, Rautava J, Syrjänen K, Grenman S, Syrjänen S.

Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2215-2219. doi: 10.1007/s10096-017-3048-y. Epub 2017 Jul 5.

PMID:
28681204
18.

Breast Milk Is a Potential Vehicle for Human Papillomavirus Transmission to Oral Mucosa of the Spouse.

Louvanto K, Sarkola M, Rintala M, Syrjänen K, Grenman S, Syrjänen S.

Pediatr Infect Dis J. 2017 Jul;36(7):627-630. doi: 10.1097/INF.0000000000001546.

PMID:
28604561
19.

The presence of human papillomavirus (HPV) in placenta and/or cord blood might result in Th2 polarization.

Koskimaa HM, Paaso A, Welters MJP, Grénman S, Syrjänen K, van der Burg SH, Syrjänen S.

Eur J Clin Microbiol Infect Dis. 2017 Aug;36(8):1491-1503. doi: 10.1007/s10096-017-2958-z. Epub 2017 Mar 21.

20.

International Women's Day - all changes matter.

Wøjdemann KR, Benedetto C, Grénman S.

Acta Obstet Gynecol Scand. 2017 Mar;96(3):261-262. doi: 10.1111/aogs.13100. No abstract available.

PMID:
28276058
21.

Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer.

Vallius T, Hynninen J, Auranen A, Matomäki J, Oksa S, Roering P, Grènman S.

Tumour Biol. 2017 Feb;39(2):1010428317691189. doi: 10.1177/1010428317691189.

PMID:
28218038
22.

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist).

Lindemann K, Gibbs E, Åvall-Lundqvist E, dePont Christensen R, Woie K, Kalling M, Auranen A, Grenman S, Hoegberg T, Rosenberg P, Skeie-Jensen T, Hjerpe E, Dørum A, Gebski V, Kristensen G.

Br J Cancer. 2017 Feb 14;116(4):455-463. doi: 10.1038/bjc.2016.435. Epub 2017 Jan 24.

23.

Physical state and copy numbers of HPV16 in oral asymptomatic infections that persisted or cleared during the 6-year follow-up.

Lorenzi A, Rautava J, Kero K, Syrjänen K, Longatto-Filho A, Grenman S, Syrjänen S.

J Gen Virol. 2017 Apr;98(4):681-689. doi: 10.1099/jgv.0.000710. Epub 2017 Apr 28.

PMID:
28100295
24.

A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources.

Gidwani K, Huhtinen K, Kekki H, van Vliet S, Hynninen J, Koivuviita N, Perheentupa A, Poutanen M, Auranen A, Grenman S, Lamminmäki U, Carpen O, van Kooyk Y, Pettersson K.

Clin Chem. 2016 Oct;62(10):1390-400. doi: 10.1373/clinchem.2016.257691. Epub 2016 Aug 18.

25.

Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube.

Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Pukkala E.

Acta Oncol. 2016 Nov;55(11):1281-1284. Epub 2016 May 5.

PMID:
27148621
26.

REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker.

Lehtinen L, Vesterkvist P, Roering P, Korpela T, Hattara L, Kaipio K, Mpindi JP, Hynninen J, Auranen A, Davidson B, Haglund C, Iljin K, Grenman S, Siitari H, Carpen O.

PLoS One. 2016 Mar 16;11(3):e0151590. doi: 10.1371/journal.pone.0151590. eCollection 2016.

27.

Genotype-specific concordance of oral and genital human papillomavirus infections among marital couples is low.

Kero K, Rautava J, Louvanto K, Syrjänen K, Grenman S, Syrjänen S.

Eur J Clin Microbiol Infect Dis. 2016 Apr;35(4):697-704. doi: 10.1007/s10096-016-2589-9. Epub 2016 Feb 12.

PMID:
26873377
28.

Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative.

Koskimaa HM, Paaso A, Welters MJ, Grénman S, Syrjänen K, van der Burg SH, Syrjänen S.

J Transl Med. 2015 Nov 25;13:370. doi: 10.1186/s12967-015-0733-4.

29.

18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer.

Vallius T, Peter A, Auranen A, Carpén O, Kemppainen J, Matomäki J, Oksa S, Roering P, Seppänen M, Grénman S, Hynninen J.

Gynecol Oncol. 2016 Jan;140(1):29-35. doi: 10.1016/j.ygyno.2015.10.018. Epub 2015 Oct 26.

PMID:
26515076
30.

Carriage of herpes simplex virus and human papillomavirus in oral mucosa is rare in young women: A long-term prospective follow-up.

Mäki J, Paavilainen H, Grénman S, Syrjänen S, Hukkanen V.

J Clin Virol. 2015 Sep;70:58-62. doi: 10.1016/j.jcv.2015.07.006. Epub 2015 Jul 8.

PMID:
26305821
31.

Levonorgestrel-releasing intrauterine system and the risk of breast cancer: A nationwide cohort study.

Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Joensuu H, Pukkala E.

Acta Oncol. 2016;55(2):188-92. doi: 10.3109/0284186X.2015.1062538. Epub 2015 Aug 4.

PMID:
26243443
32.

Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum-Taxane Chemotherapy.

Chen P, Huhtinen K, Kaipio K, Mikkonen P, Aittomäki V, Lindell R, Hynninen J, Auranen A, Grénman S, Lehtonen R, Carpén O, Hautaniemi S.

Cancer Res. 2015 Aug 1;75(15):2987-98. doi: 10.1158/0008-5472.CAN-14-3242. Epub 2015 Jun 29.

33.

Cell mediated immunity against HPV16 E2, E6 and E7 peptides in women with incident CIN and in constantly HPV-negative women followed-up for 10-years.

Paaso A, Koskimaa HM, Welters MJ, Grénman S, Syrjänen K, van der Burg SH, Syrjänen S.

J Transl Med. 2015 May 20;13:163. doi: 10.1186/s12967-015-0498-9.

34.

Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma.

Edqvist PH, Huvila J, Forsström B, Talve L, Carpén O, Salvesen HB, Krakstad C, Grénman S, Johannesson H, Ljungqvist O, Uhlén M, Pontén F, Auranen A.

Gynecol Oncol. 2015 Jun;137(3):529-37. doi: 10.1016/j.ygyno.2015.03.055. Epub 2015 Apr 7.

PMID:
25858696
35.

Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer.

Vallius T, Hynninen J, Auranen A, Carpén O, Matomäki J, Oksa S, Virtanen J, Grénman S.

Tumour Biol. 2014 Dec;35(12):12389-95. doi: 10.1007/s13277-014-2553-1. Epub 2014 Sep 5.

PMID:
25190018
36.

Oral human papillomavirus infection in men might contribute to HPV serology.

Syrjänen S, Waterboer T, Kero K, Rautava J, Syrjänen K, Grenman S, Pawlita M.

Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):237-45. doi: 10.1007/s10096-014-2223-7. Epub 2014 Aug 14.

PMID:
25116322
37.

Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland.

Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Pukkala E.

Obstet Gynecol. 2014 Aug;124(2 Pt 1):292-9. doi: 10.1097/AOG.0000000000000356.

PMID:
25004338
38.

The clearance of oral high-risk human papillomavirus infection is impaired by long-term persistence of cervical human papillomavirus infection.

Louvanto K, Rautava J, Syrjänen K, Grénman S, Syrjänen S.

Clin Microbiol Infect. 2014 Nov;20(11):1167-72. doi: 10.1111/1469-0691.12700. Epub 2014 Jul 12.

39.

Human papillomavirus 16 E2-, E6- and E7-specific T-cell responses in children and their mothers who developed incident cervical intraepithelial neoplasia during a 14-year follow-up of the Finnish Family HPV cohort.

Koskimaa HM, Paaso AE, Welters MJ, Grénman SE, Syrjänen KJ, van der Burg SH, Syrjänen SM.

J Transl Med. 2014 Feb 13;12:44. doi: 10.1186/1479-5876-12-44.

40.

Stable marital relationship protects men from oral and genital HPV infections.

Kero KM, Rautava J, Syrjänen K, Kortekangas-Savolainen O, Grenman S, Syrjänen S.

Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1211-21. doi: 10.1007/s10096-014-2061-7. Epub 2014 Feb 7.

PMID:
24504632
41.

Smoking increases oral HPV persistence among men: 7-year follow-up study.

Kero K, Rautava J, Syrjänen K, Willberg J, Grenman S, Syrjänen S.

Eur J Clin Microbiol Infect Dis. 2014 Jan;33(1):123-33. doi: 10.1007/s10096-013-1938-1. Epub 2013 Sep 13.

PMID:
24026862
42.

Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trial.

Heliövaara-Peippo S, Hurskainen R, Teperi J, Aalto AM, Grénman S, Halmesmäki K, Jokela M, Kivelä A, Tomás E, Tuppurainen M, Paavonen J.

Am J Obstet Gynecol. 2013 Dec;209(6):535.e1-535.e14. doi: 10.1016/j.ajog.2013.08.041. Epub 2013 Aug 30.

PMID:
23999423
43.

A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer.

Hynninen J, Kemppainen J, Lavonius M, Virtanen J, Matomäki J, Oksa S, Carpén O, Grénman S, Seppänen M, Auranen A.

Gynecol Oncol. 2013 Nov;131(2):389-94. doi: 10.1016/j.ygyno.2013.08.023. Epub 2013 Aug 29.

PMID:
23994535
44.

Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.

Huvila J, Talve L, Carpén O, Edqvist PH, Pontén F, Grénman S, Auranen A.

Gynecol Oncol. 2013 Sep;130(3):463-9. doi: 10.1016/j.ygyno.2013.06.015. Epub 2013 Jun 15.

PMID:
23777659
46.

Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: a six-year follow-up study.

Louvanto K, Rautava J, Willberg J, Wideman L, Syrjänen K, Grénman S, Syrjänen S.

PLoS One. 2013;8(1):e53413. doi: 10.1371/journal.pone.0053413. Epub 2013 Jan 3.

47.

Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy?

Hynninen J, Lavonius M, Oksa S, Grénman S, Carpén O, Auranen A.

Gynecol Oncol. 2013 Feb;128(2):229-32. doi: 10.1016/j.ygyno.2012.11.007. Epub 2012 Nov 9.

PMID:
23142076
48.

Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: a six-year follow-up study.

Rautava J, Willberg J, Louvanto K, Wideman L, Syrjänen K, Grénman S, Syrjänen S.

PLoS One. 2012;7(8):e42171. doi: 10.1371/journal.pone.0042171. Epub 2012 Aug 30.

49.

Oral mucosa as a reservoir of human papillomavirus: point prevalence, genotype distribution, and incident infections among males in a 7-year prospective study.

Kero K, Rautava J, Syrjänen K, Grenman S, Syrjänen S.

Eur Urol. 2012 Dec;62(6):1063-70. doi: 10.1016/j.eururo.2012.06.045. Epub 2012 Jun 28.

PMID:
22771267
50.

FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread.

Hynninen J, Auranen A, Carpén O, Dean K, Seppänen M, Kemppainen J, Lavonius M, Lisinen I, Virtanen J, Grénman S.

Gynecol Oncol. 2012 Jul;126(1):64-8. doi: 10.1016/j.ygyno.2012.04.023. Epub 2012 Apr 24.

PMID:
22542580

Supplemental Content

Loading ...
Support Center